Camlin Fine Sciences Limited has informed the Exchange about Schedule of meet
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Camlin Fine Sciences has informed the exchanges that its senior management will hold an investor and analyst conference call on Friday, 23rd May 2025 at 5:00 PM IST to discuss the audited financial results for the quarter and full year ended March 31, 2025. The call will be chaired by Chairman & MD Ashish Dandekar, MD Nirmal Momaya, and CFO Santosh Parab, with Strategic Growth Advisors managing the logistics. The company has clarified that discussions will be strictly based on publicly available information, with no unpublished price-sensitive information (UPSI) to be shared. Dial-in numbers for participants across India, USA, UK, Singapore, and Hong Kong have been provided, and the schedule may change due to exigencies.
This is a routine pre-results investor engagement and does not by itself move the stock. Shareholders should watch the actual Q4/FY25 results, which are expected to be discussed in this call on 23rd May 2025, for any material business or earnings updates.